Invested 1,726 million, "Gree" Chengkehua Bio major shareholder!

　　On May 10, Cohua Bio, Gree Real Estate both announced that LAL Corporation, the majority shareholder of Cohua Bio, transferred 18.63 percent of its shares of the company to Zhuhai Baolian, a wholly owned subsidiary of Gree Real Estate, with a transfer price of 1.726 billion yuan
According to public information, Cohua Bio is an in vitro diagnostic company based in the medical field It is also the first listed company to land in the field of in vitro diagnostics of the Shenzhen Stock Exchange' small board, which consists of instruments and reagents, and has fully automatic, flexible flux detection system solutions and supply capabilities in the fields of molecules, biochemistry and immunity
For the acquisition, Gree Real Estate said, this is mainly the company is optimistic about the acquisition of Cohua Bio in the domestic in vitro clinical diagnostic industry has a significant comprehensive competitive advantage, but also to the field of biomedicine and medical health layout to take substantial steps, improve and expand the industrial layout of the large health sector important measures
It is worth noting that this stake in Cohua Bio is not the first time Gree Real Estate has been involved in the medical industry On February 10 this year, Gree Real Estate established Zhuhai Gaoge Medical Technology Co., Ltd in a joint venture with Zhuhai Micro-Invention Technology Co., Ltd., Zhuhai Medical Kai Electronic Technology Co., Ltd After the establishment of the Gaoge medical mainly produces some medical materials
In fact, in addition to Gree real estate, in recent years we can see more and more enterprises in different industries, are using different ways, in the collective to the large health industry to test water, into Such as January 12, 2019 in Qingdao, Wanda Group 2018 annual meeting, its leaders put forward a formal entry into the big health industry, clear Wanda Health will be the hospital as the core, integrated medicine, health care, business, training a variety of industries as a whole, take a new model of innovative health industry In addition, wanda large health industry planning layout, it also put forward in Guangzhou, Chengdu and other five first-tier cities to establish a large health international hospital specific direction
On March 23, Wuliang Group also announced that it was holding hands with Sichuan Dahua West Hospital to build two nearly 10 billion yuan projects in Chengdu, Sichuan Province, for the Management Center for Medical Health and the New Economic Center Among them, Sichuan Huaxi Wuliang International Medical Management Center project to health management, medical care, rehabilitation as the focus of business layout It is reported that, as early as July 2018, Wuliang Group and Sichuan University Huaxi Hospital has reached a "one hospital, one center" project cooperation, the two sides to play their respective brand advantages, technical advantages and capital advantages, the use of production, learning, research, use, investment combined cooperation model, hand in hand to build a large health industry brand
In addition, the author also learned that the current Evergrande, Vanke and other real estate head enterprises are also through self-construction or investment in mergers and acquisitions, cross-border cooperation and other forms to join this round of large-scale health industry competition pattern More Internet companies, on the other hand, tend to use technology and big data advantages to take advantage of the big health field
In fact, the above enterprises are only a large number of cross-industry test water, into the field of large health enterprises The industry believes that behind these cross-border actions are in fact the support of national policies, the rise of the large health market caused
According to the "China's China Health Industry Strategic Planning and Enterprise Strategy Advisory Report" released by the Prospective Industry Research Institute, as of 2017, China's large health industry size of 6.2 trillion yuan By 2020, the scale of China's large-scale health industry will exceed 10 trillion yuan The compound growth rate of 2019-2023 is about 12.55 percent, and the scale of China's large-scale health industry is forecast to reach 14.09 trillion yuan in 2023
In general, the cross-border boom in the big health industry heralds the arrival of the blue sea era in the industry In the next decade, the scale and value of the big health industry will be sustained and rapid development, thus attracting more enterprises' attention and cross-border layout.